HANSOH PHARMA(03692),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

03692 HANSOH PHARMA

Closed 12-23 16:08:09

37.680

-0.720

-1.87%

High38.720	Low37.520	Vol4.95M
Open38.380	D1 Closing38.400	Amplitude3.13%
Mkt Cap228.15B	Tradable Cap228.15B	Total Shares6.06B
T/O187.57M	T/O Rate0.08%	Tradable Shares6.06B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"03692","market":"HK","secType":"STK","nameCN":"HANSOH PHARMA","latestPrice":37.68,"timestamp":1766477289009,"preClose":38.4,"halted":0,"volume":4951381,"delay":0,"floatShares":6055000000,"shares":6055000000,"eps":0.8173611307100579,"marketStatus":"Closed","change":-0.72,"latestTime":"12-23 16:08:09","open":38.38,"high":38.72,"low":37.52,"amount":187574545,"amplitude":0.03125,"askPrice":37.68,"askSize":30000,"bidPrice":37.62,"bidSize":24000,"shortable":3,"etf":0,"ttmEps":0.8902835366618184,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1766539800000},"marketStatusCode":5,"adr":0,"listingDate":1560441600000,"exchange":"SEHK","adjPreClose":38.4,"dividendRate":0.009877,"openAndCloseTimeList":[[1766453400000,1766462400000],[1766466000000,1766476800000]],"volumeRatio":0.794151,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03692","defaultTab":"news","newsList":[{"id":"2593498616","title":"Hansoh Pharmaceutical Group  Stock Slides 1.9% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2593498616","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593498616?lang=en_us&edition=fundamental","pubTime":"2025-12-23 16:30","pubTimestamp":1766478600,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Hansoh Pharmaceutical Group Co. Ltd. shed 1.9% to 37.68 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.1% to 25774.14.This was the stock's third consecutive day of losses.Hansoh Pharmaceutical Group Co. Ltd. closed 15% below its 52-week high of HK$44.22, which the company achieved Dec. 12.Trading volume totaled 5.0 million shares, compared to the 50-day average of 8.5 million shares.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","BK1191","BK1583","03692"],"gpt_icon":0},{"id":"2592190154","title":"Hansoh Pharmaceutical Group  Stock Slips 1.2% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2592190154","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592190154?lang=en_us&edition=fundamental","pubTime":"2025-12-19 16:33","pubTimestamp":1766133180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Hansoh Pharmaceutical Group Co. Ltd. slipped 1.2% to 38.50 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.8% to 25690.53.Hansoh Pharmaceutical Group Co. Ltd. closed 13% below its 52-week high of HK$44.22, which the company reached Dec. 12.Trading volume totaled 7.6 million shares, compared to the 50-day average of 8.7 million shares.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1191","03692","BK1589"],"gpt_icon":0},{"id":"1114057704","title":"HANSOH PHARMA (03692) Enters Licensing Agreement with GLENMARK for Ameitinib","url":"https://stock-news.laohu8.com/highlight/detail?id=1114057704","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114057704?lang=en_us&edition=fundamental","pubTime":"2025-12-16 18:08","pubTimestamp":1765879710,"startTime":"0","endTime":"0","summary":"HANSOH PHARMA (03692) announced that on December 16, 2025, its wholly-owned subsidiary Jiangsu Hansoh Pharmaceutical Group Co., Ltd. (Licensor) signed an exclusive licensing, collaboration, and...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1191","03692","BK1589"],"gpt_icon":0},{"id":"2591988205","title":"Hansoh Pharmaceutical Signs Exclusive License Agreement with Glenmark for Aumolertinib","url":"https://stock-news.laohu8.com/highlight/detail?id=2591988205","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591988205?lang=en_us&edition=fundamental","pubTime":"2025-12-16 18:02","pubTimestamp":1765879335,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical Group Co. Ltd. announced that its wholly-owned subsidiary, Jiangsu Hansoh Pharmaceutical Group Co., Ltd., has entered into an exclusive license, collaboration, and distribution agreement with Glenmark Specialty S.A. Under the agreement, Glenmark will have the exclusive rights to develop and commercialize Aumolertinib, a third-generation EGFR-TKI for the treatment of non-small cell lung cancer, in territories including the Middle East and Africa, Southeast & South Asia, Australia, New Zealand, Russia/CIS, and selected Caribbean countries. The agreement includes an upfront payment to Hansoh, followed by additional payments as specified in the contract. The agreement is subject to necessary regulatory filings.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nNDL4HCRP3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1583","03692","BK1589"],"gpt_icon":0},{"id":"2591882799","title":"Hansoh Pharmaceutical - Unit Enters License Agreement With Glenmark for Aumolertinib","url":"https://stock-news.laohu8.com/highlight/detail?id=2591882799","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591882799?lang=en_us&edition=fundamental","pubTime":"2025-12-16 18:02","pubTimestamp":1765879331,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nFWN3XL12L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1589","BK1583","BK1191","03692"],"gpt_icon":0},{"id":"2591274988","title":"Hansoh Pharmaceutical - Unit to Receive Over $1 Bln in Payments and Royalties","url":"https://stock-news.laohu8.com/highlight/detail?id=2591274988","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591274988?lang=en_us&edition=fundamental","pubTime":"2025-12-16 18:02","pubTimestamp":1765879331,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nFWN3XL12L:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1589","BK1583","03692","BK1191"],"gpt_icon":0},{"id":"2591619913","title":"Hansoh Pharmaceutical Group  Stock Falls 7.6% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2591619913","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591619913?lang=en_us&edition=fundamental","pubTime":"2025-12-15 16:31","pubTimestamp":1765787460,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Hansoh Pharmaceutical Group Co. Ltd. slid 7.6% to 39.74 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.3% to 25628.88.This was the stock's second consecutive day of losses.Hansoh Pharmaceutical Group Co. Ltd. closed 10% below its 52-week high of HK$44.22, which the company reached Dec. 12.Trading volume totaled 18.6 million shares, compared to the 50-day average of 8.3 million shares.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1589","03692","BK1191"],"gpt_icon":0},{"id":"2590505982","title":"FACTBOX-Weight-loss drug developers line up to tap lucrative market as competition heats up","url":"https://stock-news.laohu8.com/highlight/detail?id=2590505982","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590505982?lang=en_us&edition=fundamental","pubTime":"2025-12-12 20:04","pubTimestamp":1765541041,"startTime":"0","endTime":"0","summary":"FACTBOX-Weight-loss drug developers line up to tap lucrative market as competition heats upChanges dateline, adds new details in paragraph 19, 20, 27, 36 and 54. The weight-loss drug market is booming, with biotech firms racing to secure their place in a lucrative sector currently dominated by Novo Nordisk NOVOb.CO and Eli Lilly LLY.N.Analysts project the industry could rake in $150 billion in annual sales by the next decade.Soaring demand for its obesity treatment has helped Lilly become the first pharmaceutical company to reach","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nL4N3XI0R0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","03165","600196","LU0345777147.USD","03933","AMGN","LU1720051017.SGD","LU0130517989.USD","SG9999015986.USD","IE00BK4W5M84.HKD","LU1003077747.HKD","LU1989772840.SGD","SG9999014906.USD","LU0823434583.USD","LU1035775433.USD","LU2106854487.HKD","LU0256863902.USD","BK0028","LU0211328371.USD","SG9999013999.USD","MRK","GPCR","SG9999002224.SGD","IE00BJJMRX11.SGD","LLY","LU1989771016.USD","IE00B4JS1V06.HKD","BK0187","LU0306806265.USD","LU0106261372.USD","LU0964806797.USD","LU1061106388.HKD","03692","SGXZ99366536.SGD","VKTX","IE00BN8TJ469.HKD","LU0499090636.EUR","AZN.UK","LU1323610961.USD","IE0005OL40V9.USD","00656","SRRK","02105","MTSR","ALT","BK0188","IE00BJLML261.HKD","IE0002141913.USD","OPK"],"gpt_icon":1},{"id":"2590476945","title":"Hansoh Pharmaceutical Group (SEHK:3692) Valuation Update After New NRDL Wins for Ameile, Saint Luolai and Hengmu","url":"https://stock-news.laohu8.com/highlight/detail?id=2590476945","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590476945?lang=en_us&edition=fundamental","pubTime":"2025-12-12 04:26","pubTimestamp":1765484768,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical Group (SEHK:3692) just secured fresh National Reimbursement Drug List approvals for new Ameile indications, plus renewals for Saint Luolai and Hengmu, a policy shift that could reshape its revenue mix from 2026.\nSee our latest analysis for Hansoh Pharmaceutical Group.\nThat backdrop helps explain why sentiment has swung so hard in Hansoh’s favour, with a 30 day share price return of 18.79 percent and a one year total shareholder return of 137.26 percent signalling strong,...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3692/hansoh-pharmaceutical-group-shares/news/hansoh-pharmaceutical-group-sehk3692-valuation-update-after","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3692/hansoh-pharmaceutical-group-shares/news/hansoh-pharmaceutical-group-sehk3692-valuation-update-after","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","BK1589","BK1191","BK1583","03692"],"gpt_icon":0},{"id":"1187877700","title":"Hong Kong Market Analysis | Fed Rate Cut Fails to Stir A-Shares, Central Economic Work Conference Sets Direction","url":"https://stock-news.laohu8.com/highlight/detail?id=1187877700","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187877700?lang=en_us&edition=fundamental","pubTime":"2025-12-11 20:39","pubTimestamp":1765456757,"startTime":"0","endTime":"0","summary":"【Market Overview】Despite the Fed's rate cut, A-shares unexpectedly plunged, while Hong Kong stocks showed relative resilience with a modest 0.04% dip after a brief rally. The Federal Open Market...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"cce27d495b9fa6fa72537db5db7bf5aa","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01772","03750","BK1589","BK1594","LU1960683339.HKD","ESmain","MESmain",".SPX","UPRO","BK1583","BK4585","BK4504","OEX","LU1993786604.SGD","SSO","BK4534","BK1129","LU1807302812.USD","SPXU","09696","LU0880133367.SGD","OEF","LU1152091754.HKD","03692","BK1190","BK4588","SDS","SG9999006597.SGD","BK1610","BK4559","LU1008478684.HKD","SPY","BK1509","BK1116","BK4581","BK1592","SH","LU1152091168.USD","IVV","SG9999014674.SGD","LU0067412154.USD","SG9999003461.SGD","BK1191","BK4550"],"gpt_icon":1},{"id":"2590161594","title":"Hansoh Pharma Reports Strong Phase II Results for Resencatinib in RET-Fusion NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2590161594","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590161594?lang=en_us&edition=fundamental","pubTime":"2025-12-11 18:09","pubTimestamp":1765447750,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical Group Co. Ltd. has announced updated results from a Phase I/II clinical trial evaluating resencatinib , a highly selective RET inhibitor, for the treatment of patients with locally advanced or metastatic non-small cell lung cancer  harboring RET gene fusions. The data, presented at the ESMO ASIA Congress 2025, included findings from 326 patients with RET-altered advanced solid tumors. In the study, the confirmed objective response rate  was 80.0% in patients who had progressed after previous therapies, and 83.3% in treatment-naive patients. The disease control rate  was 96.0% and 93.3%, respectively, with 12-month progression-free survival rates of 81.1% and 79.3%. Resencatinib demonstrated a favorable tolerability and manageable safety profile in this population.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for in","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDL7sL9Hy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1589","03692","BK1191"],"gpt_icon":0},{"id":"1185919160","title":"Hong Kong Stocks Hit 52-Week Highs and Lows | Dec 11","url":"https://stock-news.laohu8.com/highlight/detail?id=1185919160","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185919160?lang=en_us&edition=fundamental","pubTime":"2025-12-11 16:49","pubTimestamp":1765442987,"startTime":"0","endTime":"0","summary":"As of the close on December 11, 28 stocks reached 52-week highs. Among them, Asia Fuxing (08413), Yuanmei Optoelectronics (08311), and Raily Aesthetic Medicine (02135) led the gains with increases of...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1541","LU1316543674.SGD","BK1552","LU0329678337.USD","01341","LU0211331839.USD","BK1161","02609","BK1610","STAN.UK","BK1542","BK1184","IE0034224299.USD","LU0634319403.HKD","BK1110","02135","BK1157","LU0164880469.USD","BK1229","BK1258","09688","03288","LU0607220059.USD","BK1156","01157","02210","00014","BK1162","00296","08311","BK1190","01937","BK1589","08413","BK1168","LU0516423091.SGD","02621","SG9999000327.SGD","01304","02431","LU2488822045.USD","02888","02023","BK1144","08391","00204","06989","00493","00701","03639","06980","BK1207","06677","06078","08349","BK1619","BK1237","01239","01709","BK1209","08623","BK1138","01790","BK1596","00145","08331","00917","SG9999014674.SGD","08310","BK1102","BK1124","BK1618","03076","BK1213","LU0048597586.USD","LU1481107354.HKD","00038","BK1105","BK1231","BK1163","BK1556","BK1171","01758","LU2226123490.SGD","LU0516422440.USD","01047","BK1548","LU0417516738.SGD","BK1106","LU0229494975.USD","LU0329678170.USD","BK1116","02699","BK1219","BK1505","02582","BK1566","BK1174","09860","00341","LU1015430645.USD","LU0149534421.HKD","BK1587","BK1129","SG9999004311.SGD","BK1228","00325","06960","BK1572","02556","BK1172","BK1588","LU0540923850.HKD","BK1543","09869","LU0516422952.EUR","BK1121","02231","BK1183","LU0737861772.HKD","LU0516422366.SGD","BK1537","BK1518","LU0251144936.SGD","SG9999001689.USD","BK1137","03143","01965","LU0575583348.USD","00632","BK1191","BK1511","BK1577","BK1593","BK1109","LU0348735423.USD","LU2226123227.USD","LU0149721374.USD","02693","LU0211977185.USD","00551","BK1601","BK1583","BK1578","03692","BK1233","BK1502","LU0516423174.USD","00139","BK1240","HSHD.SI","BK1195","01274","02378","BK1238","HSBC","02687","BK1534","BK1547","02367","02562","03633","BK1140","01855","01176","BK1094","01539","BK1221","BK1574","HSBA.UK","00005","03989","LU1880383366.USD"],"gpt_icon":1},{"id":"2590595611","title":"Hansoh Pharmaceutical Group  Stock Rallies 2.0% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2590595611","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590595611?lang=en_us&edition=fundamental","pubTime":"2025-12-11 16:30","pubTimestamp":1765441800,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Hansoh Pharmaceutical Group Co. Ltd. rose 2.0% to 43.36 Hong Kong dollars , on what proved to be an all-around mediocre trading session for the Hong Kong stock market, with the Hang Seng Index remaining mostly flat at 25530.51.This was the stock's second consecutive day of gains.Hansoh Pharmaceutical Group Co. Ltd. hit a new 52-week high, surpassing its previous peak of HK$42.78, which the company achieved Dec. 10.Trading volume totaled 8.9 million shares, compared to the 50-day average of 8.1 million shares.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1191","03692","BK1589"],"gpt_icon":0},{"id":"2590858365","title":"Hansoh Pharma Reports Promising Phase 1 Results for Risvutatug Rezetecan in Advanced NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2590858365","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590858365?lang=en_us&edition=fundamental","pubTime":"2025-12-10 17:53","pubTimestamp":1765360439,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hansoh Pharmaceutical Group Co. Ltd. published the original content used to generate this news brief on December 10, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nNDL2pQzc9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","03692","BK1583","BK1589"],"gpt_icon":0},{"id":"2589145381","title":"Hansoh Pharma Wins 2025 NRDL Approval for New Ameile Indications and Renews Multiple Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2589145381","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589145381?lang=en_us&edition=fundamental","pubTime":"2025-12-08 14:07","pubTimestamp":1765174037,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical Group Co. Ltd. announced that two new indications for its innovative drug Aumolertinib Mesilate Tablets  have been added to the 2025 National Reimbursement Drug List  in China. The new indications include treatment for adult patients with stage II to IIIB non-small cell lung cancer  with specific EGFR mutations after tumor resection, and for adult patients with locally advanced, unresectable  NSCLC with EGFR mutations whose disease has not progressed during or after platinum-based chemoradiotherapy. Additionally, all indications for the company's drugs Saint Luolai  and Hengmu  have been renewed in the 2025 NRDL. The updated NRDL will be implemented on January 1, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDL6BngwZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692","BK1589","BK1191","BK1583"],"gpt_icon":0},{"id":"2589055800","title":"Hansoh Pharmaceutical Says Two New Indications Added for Ameile in China's Reimbursement List","url":"https://stock-news.laohu8.com/highlight/detail?id=2589055800","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589055800?lang=en_us&edition=fundamental","pubTime":"2025-12-08 10:33","pubTimestamp":1765161228,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical Group  said two new indications of its lung-cancer drug Ameile were added to China's latest list of drugs eligible for reimbursement, according to a Hong Kong bourse filing Monday.The company's medicine will be eligible for reimbursement for the treatment of patients with stage II to IIIB lung cancer with a type of mutation post-surgery, as well as for use in patients with unresectable stage III cancer who haven't progressed after chemotherapy and have the same mutation.Meanwhile, all indications of Saint Luolai and Hengmu were renewed for chronic kidney disease-related anemia and chronic hepatitis B, respectively, the firm said.The updated list takes effect on Jan. 1, 2026, the firm said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1583","BK1191","03692","BK1589"],"gpt_icon":0},{"id":"1199213902","title":"Hong Kong Stock Short Selling Stats | Dec 8","url":"https://stock-news.laohu8.com/highlight/detail?id=1199213902","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199213902?lang=en_us&edition=fundamental","pubTime":"2025-12-08 08:29","pubTimestamp":1765153749,"startTime":"0","endTime":"0","summary":"The top three stocks by short-selling ratio in the previous trading session were SHK PPT-R (80016), CHINARES BEER-R (80291), and AIA-R (81299), all at 100.00%. The top three stocks by short-selling...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0384037296.USD","LU1188198961.HKD","BK1505","BK1604","IE00BZ08YT58.USD","IE00B3M56506.USD","LU0370786039.SGD","LU0047713382.USD","LU0329678337.USD","BK1577","LU0072462343.USD","BK4543","LU0359201612.USD","LU0054450605.USD","IE00B031J352.USD","01579","LU2045819591.USD","LU2152927971.USD","LU0441854154.USD","03690","LU2242644610.SGD","BK4534","SG9999015945.SGD","SG9999001689.USD","82318","BK1154","LU1868837565.USD","BK1161","LU0348735423.USD","BK1152","LU0880133367.SGD","LU0516423174.USD","LU2293587155.HKD","LU0862451753.SGD","LU0577902538.SGD","LU1303224171.USD","LU0327786744.USD","LU1366334651.USD","LU0648948544.HKD","LU0633140727.USD","LU0348816934.USD","LU1522347837.USD","LU0516423091.SGD","02318","LU0469268626.HKD","LU1328615791.USD","LU1956131251.USD","BK1227","BK1191","00136","SG9999003461.SGD","LU0455707207.USD","BK1522","LU0543330566.HKD","LU0289961442.SGD","HK0000500386.USD","XIACY","LU0048597586.USD","BABA","LU0819121731.USD","BK1618","LU0531970944.HKD","LU1224709979.USD","LU0211977185.USD","BK4579","LU0084288322.USD","LU0856984785.SGD","LU0588545730.USD","LU0196878994.USD","LU0823413587.USD","BK1095","LU0541502299.USD","LU0228367735.SGD","LU0348827113.USD","LU0605514214.HKD","LU1688375341.USD","SG9999015952.SGD","SG9999001903.USD","LU1282649141.HKD","BK1610","BK1594","LU0049112450.USD","LU1282649067.USD","BK1539","IE00BWDBJ730.SGD","LU0828237510.HKD","00939","LU1720050803.USD","LU0043850808.USD","LU1044874839.SGD","BYDDY","BK1184","LU0499858602.USD","LU0828238088.HKD","LU1046421795.USD","BK1502","HK0000165453.HKD","LU0140636845.USD","IE00BZ08YS42.EUR","LU0181495838.USD","BK4527","LU0417516902.SGD","SG9999001093.SGD","BK1582","IE00B5MMRT66.SGD","LU0823426480.USD","LU0348814723.USD","81299","LU0029875118.USD","IE00B031HY20.USD","IE00BZ08YR35.GBP","BK1544","LU1823568750.SGD","LU1861214812.USD","LU1064131003.USD","LU0456827905.SGD","LU0577902371.SGD","LU0197773160.USD","LU0345775950.USD","LU1051769294.HKD","80291","LU0572944931.SGD","LU0865486749.SGD","LU0235996351.USD","LU1282649810.SGD","LU2097828805.USD","LU0873338254.USD","LU2449936058.SGD","LU0039217434.USD","LU0266512127.USD","LU0871576103.HKD","LU0061477393.USD","IE0034224299.USD","LU0052750758.USD","LU0516422440.USD","80700","LU0326950275.SGD","LU0516422952.EUR","LU1504937902.USD","LU0164872284.USD","LU2039709279.SGD","LU0572940350.SGD","LU0630378692.HKD","LU0417516571.SGD","80016","LU0823397285.USD","LU2097828631.EUR","LU0868486357.SGD","LU0577902611.USD","HMTD.SI","LU0011963245.USD","LU1769817096.USD","LU1969619763.USD","LU1734074674.USD","LU1008478684.HKD","IE0008369823.USD","BK1589","LU0261950983.USD","LU1642822792.SGD","01810","BK4614","LU1048588211.SGD","LU0823397103.USD","LU0106252389.USD","LU0244354667.USD","82331","BK1592","LU0345776255.USD","IE00BF5LJ272.USD","BK1591","BK4122","LU0345780281.USD","LU1981816686.USD","SG9999006597.SGD","00341","LU0320764755.SGD","BK1590","SG9999006514.SGD","BK1550","LU0791591158.USD","LU0878004406.USD","LU1267930227.SGD","LU0516422366.SGD","LU0396098781.USD","LU1282651048.USD","LU2778985437.USD","81810","601318","LU0577902454.USD","03143","LU1102505929.USD","LU0819123356.HKD","MIUmain","LU0143863784.USD","09988","80941","LU0315178854.USD","LU1497733557.USD","BK4502","LU0882747503.HKD","81211","LU1224444064.USD","BK1233","LU1323998911.USD","LU1719994722.HKD","LU1003077747.HKD","SG9999015978.USD","LU0359202008.SGD","METmain","LU0345780521.USD","ALBmain","LU0169518387.USD","LU0348788117.USD","BK1119","LU0594300419.USD","LU1880383366.USD","LU0918141705.HKD","LU0499858438.USD","LU1226287529.USD","LU0634319403.HKD","LU0310800965.SGD","LU1769817179.HKD","LU0540923850.HKD","LU0737861699.HKD","LU0531971595.HKD","BK4504","LU0289739343.SGD","BK4533","HK0000252160.HKD","LU0251144936.SGD","IE0003895053.USD","LU1960683339.HKD","LU1861219969.SGD","LU0259732245.USD","LU0049853897.USD","89888","LU0543330483.HKD","IE00BFMHRM44.USD","LU0823038988.USD","LU2153592121.USD","LU1868838027.USD","HXXD.SI","LU0348805143.USD","LU1152091754.HKD","LU1808992512.USD","LU0878005551.USD","LU1481107354.HKD","BK4565","BK1575","LU0254981946.USD","LU0918141887.USD","LU0431992006.USD","BK1601","BK1607","LU0348783233.USD","SG9999000327.SGD","LU1880383440.USD","PAImain","IE00B19Z5X02.USD","LU1152091168.USD","BK1193","LU0314109678.HKD","BK1216","LU0197773673.USD","SG9999001226.SGD","LU2148611432.USD","LU1831875114.USD","LU0594300179.USD","LU0328353924.USD","IE00BYV24P56.USD","BK1588","LU1568876251.USD","00916","LU0287142896.SGD","BK1609","LU0738911758.USD","LU0067412154.USD","LU0173614495.USD","BK1560","HK0000306685.HKD","LU0307460666.USD","LU1282651121.HKD","LU0823414551.USD","BK1180","03968","LU0505663152.USD","BK4526","LU1813983027.USD","LU0096374516.USD","BK4588","HK0000320264.USD","BK4607","BK1547","LU0417516738.SGD","02899","BK4503","LU2399975544.HKD","BK1142","BK1540","LU0456854461.SGD","BK4531","LU0315179316.USD","LU0052756011.USD","LU1211504680.USD","LU0561508036.HKD","LU1634259557.SGD","LU0449509016.USD","LU1961090484.USD","LU0797268264.HKD","IE0032431581.USD","BK4220","LU0762540952.USD","LU0791590937.USD","LU2357125470.USD","LU2087589342.USD","LU0175139822.USD","LU0886674414.USD","09888","LU0329678170.USD","LU0633140560.USD","LU0326948709.USD","LU0511384066.AUD","LU0463099449.HKD","01211","BK1587","LU0651947912.USD","LU2476274308.USD","LU0132412106.USD","LU0106959298.USD","LU0456846285.SGD","LU0630378429.USD","LU1051768304.USD","SG9999000459.SGD","BK1523","BK1558","LU2148510915.USD","HYDD.SI","LU0082770016.USD","LU0828237940.HKD","002594","LU0651946864.USD","LU0501845795.SGD","LU0831093199.SGD","LU2097828714.EUR","LU1102505762.USD","LU0128522157.USD","LU0553294199.USD","BK1507","LU1251922891.USD","LU2097828474.EUR","BK4535","LU0541501648.USD","LU0274383008.USD","LU0661504455.SGD","LU0165289439.USD","LU0762542818.HKD","LU0348825331.USD","03145","BK4587","LU0672654166.SGD","82388","LU1048484197.HKD","LU0143863198.USD","LU0588545904.SGD","PNGAY","BK1198","LU0228659784.USD","BK4554","LU2125910500.SGD","SG9999002562.SGD","BK1231","BK1598","LU0890818403.SGD","IE00BPRC5H50.USD","LU2213484517.USD","LU0588546209.SGD","LU1046422090.SGD","LU0163747925.USD","BK1521","LU0823040885.USD","BK4575","LU0675040207.SGD","LU2506951792.HKD","LU0320764599.SGD","LU2226246903.HKD","TCHmain","IE00BQJZWZ67.USD","LU1328277881.USD","LU2294711713.HKD","LU1770036033.HKD","BK4558","LU1115378108.SGD","LU0048580855.USD","LU0289960550.SGD","LU0737861772.HKD","BK4585","LU0762541174.USD","LU1235295612.USD","SG9999007991.SGD","SG9999013353.USD","LU1568876335.HKD","LU1064130708.USD","HK0000252152.HKD","IE00B0JY6N72.USD","IE00BVYPNQ40.USD","LU0545039389.USD","LU1242518931.SGD","LU2360107325.USD","IE00BVYPNP33.GBP","LU0823039010.USD","LU1497734951.SGD","LU0210526637.USD","SG9999002828.SGD","LU0823041008.USD","LU0054237671.USD","LU0589944569.HKD","BK1509","LU0823413660.USD","LU2097828557.USD","LU0348783662.USD","IE00BD6J9T35.USD","LU1044876610.USD","LU2249611893.SGD","LU0577902298.EUR","LU0488056044.USD","LU0700851271.USD","LU1044875133.USD","LU0359201885.HKD","LU1807302812.USD","LU0051755006.USD","LU1515016050.SGD","LU2488822045.USD","LU0269904917.USD","LU0611395673.USD","LU0509642566.USD","LU1366334578.USD","LU0640798160.USD","BK1128","LU1675838814.USD","BK1506","LU0164880469.USD","LU1993786604.SGD","LU2476274720.SGD","LU0149721374.USD","LU2328871848.SGD","BK1516","LU0502904849.HKD","LU0821914370.USD","LU0588545490.SGD","LU1634259391.SGD","IE00BMCWC346.EUR","SG9999015986.USD","LU0593848301.USD","BK4524","LU2257852520.SGD","LU0128525689.USD","LU1023057109.AUD","LU0979878070.USD","LU0072913022.USD","MPNGY","BK1615","LU1794554557.SGD","SG9999002463.SGD","LU1048596156.SGD","LU0251143458.SGD","LU0266512473.USD","BIDU","LU0164865239.USD","IE00BGHQDM52.EUR","BK1583","HK0000320223.HKD","LU1105468828.SGD","SG9999014674.SGD","IE00B29SXG58.USD","IE00B543WZ88.USD","LU0293314216.USD","LU0229945570.USD","BK4538","LU0231483743.USD","LU0823426308.USD","BK4505","LU0214875030.USD","LU1242518857.USD","BK4548","LU0650527681.SGD","LU0823414478.USD","LU1770034418.SGD","LU0572939691.SGD","LU1282648689.USD","03692","LU0117841782.USD","01801","IE0031814852.USD","IE0008368742.USD","LU0949170772.SGD","BK1237","LU0264606111.USD","LU0348784397.USD","LU0708995583.HKD","LU2348774022.SGD","LU1868837722.USD","LU1235294995.USD","SG9999004220.SGD","LU0683595622.HKD","LU1497733631.SGD","HPAD.SI","BK4581","LU0449515922.USD","HK0000306701.USD"],"gpt_icon":1},{"id":"1125990923","title":"HANSOH PHARMA (03692): Two New Indications for Innovative Drug Ameile® Successfully Included in 2025 National Reimbursement Drug List","url":"https://stock-news.laohu8.com/highlight/detail?id=1125990923","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125990923?lang=en_us&edition=fundamental","pubTime":"2025-12-08 07:08","pubTimestamp":1765148901,"startTime":"0","endTime":"0","summary":"HANSOH PHARMA (03692) announced that two new indications for its innovative drug Ameile® have been successfully included in the updated National Reimbursement Drug List (NRDL) for 2025, covering...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692","BK1161","BK1191","06978","159992","BK1589","BK1583","BK1574"],"gpt_icon":0},{"id":"1134242259","title":"Hong Kong Stocks: 52-Week Highs and Lows as of December 5","url":"https://stock-news.laohu8.com/highlight/detail?id=1134242259","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134242259?lang=en_us&edition=fundamental","pubTime":"2025-12-05 16:42","pubTimestamp":1764924161,"startTime":"0","endTime":"0","summary":"As of the close on December 5, 36 stocks hit 52-week highs, with China Kingstone (01380), Zhongneng Holdings (02971), and Tian Cheng Holdings (02110) leading the gains at 40.21%, 28.57%, and 26.67%,...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1993786604.SGD","02693","06616","08195","LU0821914370.USD","BK1219","01615","IE00B0169L03.USD","BK1587","BK1209","06108","BK1548","LU1515016050.SGD","08021","LU1224709979.USD","03913","00550","BK1225","BK1214","00300","SG9999011746.SGD","06989","01283","06603","06911","09929","BK1115","BK1237","LU1048596156.SGD","BK1566","BK1148","01757","BK1137","BK1585","LU1981816686.USD","LU1807302812.USD","BK1140","BK1538","03692","BK1170","BK1104","06960","08619","08360","01957","BK1205","BK1129","LU0211331839.USD","LU0877626530.USD","BK1143","BK1183","00693","02688","02110","BK1221","LU0205439572.USD","01380","01993","BK1181","IE0008368742.USD","00146","LU0048597586.USD","LU0251144936.SGD","02378","BK1156","02670","BK1116","BK1230","02971","02683","BK1144","BK1228","02865","02650","LU1880383366.USD","03808","BK1511","BK1555","00034","02508","02798","BK1171","01163","BK1507","LU1051768304.USD","LU1960683339.HKD","06805","08371","BK1191","BK1163","BK1233","BK1542","LU2048586759.USD","02609","01752","08125","03686","BK1184","BK1589","02788","02188","BK1190","BK1240","01146","BK1583","LU0651946864.USD","BK1227","LU0737861699.HKD","BK1258","08321","LU0287142896.SGD","00115","02522","01813","BK1229","BK1521","02431","00873","00938","01557","01198","06933","LU1119993845.HKD","01274","BK1151","LU0173614495.USD","01740","00205","BK1124","00139"],"gpt_icon":1},{"id":"2588000493","title":"Hansoh Pharmaceutical Group  Stock Climbs 0.7% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2588000493","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588000493?lang=en_us&edition=fundamental","pubTime":"2025-12-04 16:33","pubTimestamp":1764837180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Hansoh Pharmaceutical Group Co. Ltd. inched 0.7% higher to 40.46 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.7% to 25935.90.Hansoh Pharmaceutical Group Co. Ltd. closed 2.1% short of its 52-week high of HK$41.34, which the company achieved Nov. 27.Trading volume totaled 6.1 million shares, compared to the 50-day average of 7.9 million shares.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1191","03692","BK1589"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0337},{"period":"1month","weight":0.0058},{"period":"3month","weight":0.0971},{"period":"6month","weight":0.3252},{"period":"1year","weight":1.1644},{"period":"ytd","weight":1.2471}],"compareEarnings":[{"period":"1week","weight":0.0067},{"period":"1month","weight":0.0231},{"period":"3month","weight":-0.0137},{"period":"6month","weight":0.0542},{"period":"1year","weight":0.3084},{"period":"ytd","weight":0.2862}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Hansoh Pharmaceutical Group Company Ltd is an investment holding company primarily engaged in the research and development, production and sale of a series of pharmaceutical products. The Company’s innovative drug products include Ameile, Hansoh Xinfu, Mailingda, Fulaimei, Hengmu, XINYUE, Saint Luolai and other products. The Company’s drug products are mainly used in oncology, anti-infective diseases, central nervous system (CNS) diseases, metabolic diseases and other therapeutic areas. The Company mainly conducts its business in the domestic market.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":-0.014633},{"month":2,"riseRate":0.5,"avgChangeRate":0.00076},{"month":3,"riseRate":0.333333,"avgChangeRate":0.024785},{"month":4,"riseRate":0.5,"avgChangeRate":0.03201},{"month":5,"riseRate":0.666667,"avgChangeRate":0.019349},{"month":6,"riseRate":0.666667,"avgChangeRate":0.055622},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.000332},{"month":8,"riseRate":0.714286,"avgChangeRate":0.01897},{"month":9,"riseRate":0.571429,"avgChangeRate":-0.033021},{"month":10,"riseRate":0.142857,"avgChangeRate":0.001586},{"month":11,"riseRate":0.714286,"avgChangeRate":0.063467},{"month":12,"riseRate":0.571429,"avgChangeRate":0.025098}],"exchange":"SEHK","name":"HANSOH PHARMA","nameEN":"HANSOH PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"HANSOH PHARMA(03692),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest HANSOH PHARMA(03692) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"HANSOH PHARMA,03692,HANSOH PHARMA股票,HANSOH PHARMA股票老虎,HANSOH PHARMA股票老虎国际,HANSOH PHARMA行情,HANSOH PHARMA股票行情,HANSOH PHARMA股价,HANSOH PHARMA股市,HANSOH PHARMA股票价格,HANSOH PHARMA股票交易,HANSOH PHARMA股票购买,HANSOH PHARMA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"HANSOH PHARMA(03692),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest HANSOH PHARMA(03692) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}